95-122
FINALPhiladelphia
76ers
28-50|L10: 2-8
Toronto
Raptors
52-35|L10: 5-5
-
//
Sports
- All Players
- Seasons
Eastern Conference
Western Conference
More
Sign in
Sign in and connect Sleeper to unlock personalized fantasy insights.
Philadelphia 76ers
Toronto Raptors
| # | Team | W-L | Pct | GB |
|---|---|---|---|---|
| 1 | 51-26 | 0.662 | — | |
| 2 |
| Opponent | Date | Result |
|---|---|---|
| 11/27 | L 108-112 | |
| 11/25 |
| 48-29 |
| 0.623 |
| 3.0 |
| 3 | 48-30 | 0.615 | 3.5 |
| 4 | 48-30 | 0.615 | 3.5 |
| 5 | 42-35 | 0.545 | 9.0 |
| 6 | 41-39 | 0.512 | 11.5 |
| 7 | 39-39 | 0.500 | 12.5 |
| 8 | 39-39 | 0.500 | 12.5 |
| 9 | 39-41 | 0.487 | 13.5 |
| 10 | 35-44 | 0.443 | 17.0 |
| 11 | 30-49 | 0.380 | 22.0 |
| 12 | 28-50 | 0.359 | 23.5 |
| 13 | 28-50 | 0.359 | 23.5 |
| 14 | 50-103 | 0.327 | 39.0 |
| 15 | 0-0 | 0.000 | 12.5 |
| 11/23 | L 99-104 |
| 11/21 | W 101-94 |
| 11/19 | W 120-105 |
| Opponent | Date | Result |
|---|---|---|
| 11/25 | W 105-99 | |
| 11/23 | W 115-102 | |
| 11/21 | L 115-123 | |
| 11/20 | L 99-102 | |
| 11/18 | W 113-111 |
| Player | PointsPPG | FG% | 3P% | FT% |
|---|---|---|---|---|
| 20.6 | 46.9% | 33.5% | 78.9% | |
| 14.9 | 43.8% | 36.6% | 63.4% | |
| 13.0 | 39.3% | 29.5% | 60.1% |
| Player | PointsPPG | FG% | 3P% | FT% |
|---|---|---|---|---|
| 26.5 |
| 16.7% |
| 82.8% |
| 21.6 | 46.7% | 41.1% | 80.3% |
| 13.9 | 44.0% | 40.4% | 50.2% |
| Category | TOR Offense | PHI Defense | Advantage |
|---|---|---|---|
Offensive RatingPoints scored per 100 possessions | #790.3 ORtg | #13106.4 DRtg | TOR |
Turnover RateLower offensive turnovers vs defensive forced turnovers | #410.3% | #514.3% | Even |
3P% vs AllowedPerimeter efficiency vs perimeter defense | #1435.9% | #1035.3% | PHI |
| Category | TOR Defense | PHI Offense | Advantage |
|---|---|---|---|
Offensive RatingPoints allowed per 100 possessions | #7105.5 DRtg | #2784.7 ORtg | PHI |
Turnover RateDefensive takeaways vs offensive giveaways | #614.3% | #2913.3% | TOR |
3P% vs AllowedPerimeter defense vs perimeter shooting | #1736.1% | #2334.3% | PHI |
